Anzeige
Mehr »
Lynx Broker
Login
Donnerstag, 24.10.2019 Börsentäglich über 12.000 News von 614 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JBKZ ISIN: GB00BF5G6K95 Ticker-Symbol: RQE1 
Frankfurt
23.10.19
15:36 Uhr
1,660 Euro
+0,120
+7,79 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
RENEURON GROUP PLC Chart 1 Jahr
5-Tage-Chart
RENEURON GROUP PLC 5-Tage-Chart

Aktuelle News zur RENEURON Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiReNeuron presents new data on CTX stem cell platform-
MiProactive news snapshot: ReNeuron, EQTEC, ADM Energy, Midatech Pharma …-
MiReNeuron Shares Jump As Lead Cell Line Shows Further Potential-
RENEURON Aktien jetzt im kostenlosen Demokonto handeln!
MiReNeuron to present new stem cell data to Barcelona conference-
MiReNeuron to present data showing "significant advance" of CTX treatment-
MiReNeuron Group plc: ReNeuron's lead cell line shows further potential-
17.10.ReNeuron Group plc: Notification of Major Holdings1
17.10.ReNeuron Group plc: Notification of Major Holdings1
17.10.EuroBiotech Report-Healx and Abalos raise cash, Ipsen bags Blueprint drug, Gilead and ReNeuron11
14.10.Proactive snapshot: Iofina, Bacanora Lithium, ReNeuron2
14.10.ReNeuron shares clinical data on stem cell vision loss therapy-
14.10.ReNeuron cell-based treatment hailed by leading non-profit group funding research into treatments for retinal degenerative diseases-
14.10.ReNeuron presents positive clinical trial data at San Francisco conference1
14.10.ReNeuron Group plc: Positive clinical data presented at AAO meeting2
02.10.ReNeuron Reports Mixed Results For Retinitis Pigmentosa Trial1
02.10.ReNeuron reports mixed results from blindness disease treatment trial2
02.10.ReNeuron hails "clear signal" from retinitis pigmentosa trials1
02.10.ReNeuron Group plc: Clinical Update and Conference Presentations1
12.09.ReNeuron Group plc: Result of AGM-
10.09.ReNeuron Group In Licensing Discussions; Faces Delay In CTX Trial-
Seite:  Weiter >>
80 Nachrichten in den letzten 12 Monaten

Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1